Amundi
RVMD icon

Amundi’s Revolution Medicines RVMD Stock Holding History

Amundi’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.5M Buy
269,701
+131,141
+95% +$19.2M 0.01% 611
2026
Q1 		$13.5M Buy
138,560
+118,493
+590% +$12M ﹤0.01% 830
2025
Q4 		$1.6M Buy
+20,067
New +$1.32M ﹤0.01% 1196
2022
Q4 		– Sell
-5,611
Closed -$109K – 1968
2022
Q3 		$109K Hold
5,611
– – ﹤0.01% 1541
2022
Q2 		$131K Buy
+5,611
New +$109K ﹤0.01% 1411

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Amundi's RVMD Position: Q2 2026 in Review

Amundi increased its Revolution Medicines (RVMD) stake by 95% in Q2 2026, buying an estimated $19.2M and bringing the position to 269,701 shares worth $50.5M. The position accounts for 0.01% of the portfolio, ranked #611.

Amundi first reported a position in RVMD in Q2 2022 and has held it in 5 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Amundi held 269,701 shares of Revolution Medicines worth $50.5M as of Q2 2026.
  • Amundi bought 131,141 Revolution Medicines shares in Q2 2026, an estimated $19.2M.
  • Revolution Medicines made up 0.01% of Amundi's portfolio in Q2 2026, its #611 holding.
  • Amundi first reported a position in Revolution Medicines in Q2 2022 and has held it in 5 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.